Cyclacel Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -5370%. Total operating expenses were $25,873,000.
Profit Margin
| 2014 | 1.73M | -19.38M | -1118.05% |
|---|---|---|---|
| 2015 | 1.94M | -14.34M | -737.76% |
| 2016 | 843K | -11.79M | -1398.7% |
| 2017 | 0 | -7.47M | |
| 2018 | 150K | -7.28M | -4858.67% |
| 2019 | 0 | -7.82M | |
| 2020 | 0 | -8.44M | |
| 2021 | 0 | -18.88M | |
| 2022 | 0 | -21.19M | |
| 2023 | 420K | -22.55M | -5370.24% |
CYCCP Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 420K | 0 | 0 | 0 | 0 | 150K | 0 | 843K | 1.94M | 1.73M |
Cost of revenue | 0 | 32K | 43K | 20K | 20K | 4.32M | 32K | 9.47M | 12.38M | 18.27M |
Gross profit | 420K | -32K | -43K | -20K | -20K | -4.17M | -32K | -8.63M | -10.43M | -16.54M |
Operating exp. | ||||||||||
Research and development | 19.15M | 20.27M | 15.47M | 4.75M | 4.65M | 4.32M | 4.23M | 9.47M | 12.38M | 18.27M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20K | 0 |
Total operating expenses | 25.87M | 27.65M | 22.93M | 10.63M | 9.68M | 9.69M | 9.49M | 14.99M | 18.13M | 24.17M |
Operating income | -25.45M | -27.65M | -22.93M | -10.63M | -9.68M | -9.54M | -9.49M | -14.15M | -16.17M | -22.43M |
Other income (expenses), net | -98K | 1.74M | 204K | 955K | 556K | 592K | 1.02M | 339K | -316K | -212K |
Income before tax | -25.55M | -25.91M | -22.73M | -9.68M | -9.12M | -8.62M | -8.46M | -13.77M | -16.48M | -22.64M |
Income tax expense | -2.99M | -4.71M | -3.84M | -1.23M | -1.29M | -1.33M | -993K | -1.98M | -2.14M | -3.24M |
Net income | -22.55M | -21.19M | -18.88M | -8.44M | -7.82M | -7.28M | -7.47M | -11.79M | -14.34M | -19.38M |
Earnings per share | ||||||||||
Basic EPS | -26.75 | -32.23 | -31.74 | -34.86 | -143.88 | -12.05 | -19.58 | -68.85 | -105.72 | -211.93 |
Diluted EPS | -26.75 | -32.23 | -31.74 | -34.86 | -143.88 | -12.05 | -19.58 | -68.85 | -105.72 | -211.93 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |